Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166464 | SCV000217261 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-31 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Counsyl | RCV000412280 | SCV000488850 | likely benign | Melanoma, cutaneous malignant, susceptibility to, 3 | 2016-07-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001082578 | SCV000559053 | likely benign | Familial melanoma | 2025-01-23 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000613863 | SCV000729564 | likely benign | not specified | 2017-04-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000759739 | SCV000889268 | benign | not provided | 2022-12-21 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000613863 | SCV002555778 | likely benign | not specified | 2022-06-09 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000412280 | SCV004020062 | benign | Melanoma, cutaneous malignant, susceptibility to, 3 | 2023-03-07 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
True Health Diagnostics | RCV000166464 | SCV000787989 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-08 | no assertion criteria provided | clinical testing |